Key insights
- Clorox priced a $1.5 billion debt offering across three tranches to repay existing debt. The tightening of credit spreads during the pricing process suggests moderate investor confidence in Clorox's creditworthiness. However, this is primarily company-specific and has limited implications for broader US equity market movements.
Investing.com -- Clorox Co (NYSE:CLX) priced a $1.5 billion debt offering on Wednesday, split into three tranches with maturities ranging from five to 10 years.
The company issued $550 million in five-year notes maturing May 15, 2031, with a 4.700% coupon and priced at 99.995 to yield 4.701%. The spread was set at 70 basis points, tighter than initial guidance of 70 basis points and down from an initial price talk of 105 basis points.
A $400 million seven-year tranche maturing May 15, 2033, carries a 4.950% coupon and was priced at 99.847 to yield 4.976%. The spread was 80 basis points, matching guidance and below the initial 115 basis points area.
The largest portion, $550 million in 10-year notes maturing May 15, 2036, has a 5.250% coupon and was priced at 99.999 to yield 5.25%. The spread was set at 90 basis points, in line with guidance and tighter than the 125 basis points initial price talk.
The notes are expected to be rated Baa1 by Moody’s and BBB by S&P. All three tranches are SEC-registered senior unsecured notes with a change of control provision at 101 and make-whole call features.
Clorox will use proceeds to repay outstanding debt under its delayed draw term credit agreement, with any remaining funds allocated for general corporate purposes. Settlement is scheduled for May 11, 2026.
Citigroup, JPMorgan and Wells Fargo Securities are bookrunners on the deal.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.